Compositions and methods relating to reduction of symptoms of autism

   
   

Methods and compositions that can reduce the symptoms of autism in a human patient comprising administering a physiologically effective amount of one or both of a purified casomorphin inhibitor selected from the group consisting of a casomorphinase and a casomorphin ligand, and a physiologically effective amount of a purified gluteomorphin inhibitor selected from the group consisting of a gluteomorphinase and a gluteomorphin ligand, to a human patient in sufficient quantities to reduce the effects of the autism. In some embodiments, the compositions and methods further comprise a physiologically effective amount of an enkephalin inhibitor, preferably an enkephalinase, and a physiologically effective amount of an endorphin inhibitor, preferably an endorphinase.

Методы и составы могут уменьшить симптомы autism в людском пациенте состоя из administering физиологически эффективное количество одного или оба из очищенного иа АБС битор casomorphin выбранного от группы consist of casomorphinase и ligand casomorphin, и физиологически эффективное количество очищенного иа АБС битор gluteomorphin выбрали от группы consist of gluteomorphinase и ligand gluteomorphin, к людскому пациенту в достаточно количествах для уменьшения влияний autism. В некоторых воплощениях, составы и методы более дальнейшие состоят из физиологически эффективного количества иа АБС битор enkephalin, предпочтительн enkephalinase, и физиологически эффективного количества иа АБС битор endorphin, предпочтительн endorphinase.

 
Web www.patentalert.com

< Treatment of helicobacter with isothiocyanates

< Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles

> Methods and compositions for promoting the maturation of monocytes

> Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions

~ 00146